Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2020 21:13 ET | Source: Aequus Pharmaceuticals

Aequus Announces Issuance of Stock Options

VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
November 30, 2020 09:00 ET | Source: Aequus Pharmaceuticals

Aequus Provides Third Quarter 2020 Financial Highlights

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
November 12, 2020 20:30 ET | Source: Aequus Pharmaceuticals

Aequus Announces Anne Stevens’ Leadership Change

VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and...
October 29, 2020 08:00 ET | Source: Aequus Pharmaceuticals

Aequus Receives Approval for New ‘Evolve - Daily Intensive’ Lubricating Eye Drops in Canada

VANCOUVER, British Columbia, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
October 19, 2020 08:00 ET | Source: Aequus Pharmaceuticals

Aequus Receives Approval for New ‘Evolve - Intensive Gel’ Lubricating Eye Drops in Canada

VANCOUVER, British Columbia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
October 16, 2020 08:00 ET | Source: Aequus Pharmaceuticals

Aequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in Canada

VANCOUVER, British Columbia, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today that it has agreed to an extension...
September 22, 2020 09:37 ET | Source: Aequus Pharmaceuticals

Aequus Announces Expansion of Medicom Partnership and Filing with Health Canada for Additional Evolve Dry Eye Product

VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
September 14, 2020 12:50 ET | Source: Aequus Pharmaceuticals

Aequus Announces Filing of New Medical Device License for Evolve Dry Eye Products in Canada

VANCOUVER, British Columbia, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
August 31, 2020 08:30 ET | Source: Aequus Pharmaceuticals

Aequus Prepares for Health Canada Regulatory Filing as Partner Receives MDSAP Certificate for Dry Eye Products

VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
August 27, 2020 21:30 ET | Source: Aequus Pharmaceuticals

Aequus Provides General Update and Second Quarter 2020 Financial Highlights

VANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...